Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial Results may not assuage concern about therapy’s competitiveness

https://www.statnews.com/2025/08/26/eli-lilly-oral-glp-1-drug-orforglipron-phase-3-trial-results/